Skip to content
Zimmermann, N; Thormann, V; Hu, B; Kohler, AB; Imai-Matsushima, A; Locht, C; Arnett, E; Schlesinger, LS; Zoller, T; Schurmann, M; Kaufmann, SHE; Wardemann, H, Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis.
Williams, EA; Lewis, DJM; Bertholet, S; Zazzi, M. Anticipating policy considerations for a future HIV vaccine: a preliminary study.
Sinha, A; Dey, A; Saletti, G; Samanta, P; Chakraborty, PS; Bhattacharya, MK; Ghosh, S; Ramamurthy, T; Kim, JO; Yang, JS; Kim, DW; Czerkinsky, C; Nandy, RK. Circulating Gut-Homing (alpha(4)beta(+)(7)) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.
Perdomo C. Zedler U., kuhl A, Lozza L, Saikali P, Sander L, Vogelzang A, Kaufmann S, Kupz A. Mucosal BCG vaccination induces protective lung resident memory T cell populations against Tuberculosis.
Boer, MC; van Meijgaarden, KE; Goletti, D; Vanini, V; Prins, C; Ottenhoff, THM; Joosten, SA. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults .
Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D’Agostino G, denelon G, Rezzonico Jost T, Grassi F, Raeli L, Schoeni-Affolter F, Stahl-Hennig C, Uguccioni M. Impairment of CCR6+ and CXCR3+ Th Cell migration in HIV-1 infection is rescued by modulating actin polymerization .
January Weiner and Stefan H.E. Kaufmann. High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers .
Stefan H.E. Kaufmann, January Weiner, C. Fordham von Reyn. Novel approaches to TB vaccine development .
Anselmo A, Riva F, Gentile S, Soldani C, Barbagallo M, Mazzon C, Feruglio F, Polentarutti N, Somma P, Carullo P, Angelini C, Bacci M, Mendolicchio GL, Voza A, Nebuloni M, Mantovani A, Garlanda C. Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets.
Alexander Badamchi-Zadeh, Paul F McKay, Martin J Holland, Wayne Paes, Andrzej Brzozowski, Charles Lacey, Frank Follmann, John S Tregoning, Robin J Shattock. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
Badamchi-Zadeh A, McKay PF, Korber BT, et al. A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearanc.
Badamchi-Zadeh A, McKay PF, Korber BT, et al. A4. Barocchi Michèle A., Black Steve, Rappuoli Rino. Multicriteria decision analysis and core values for enhancing vaccine-related decision-making.
Billeskov R, Tan EV, Cang M, Abalos RM, Burgos J, Pedersen BV, Christensen D, Agger EM, Andersen P. Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis.
Bonacina F, Barbieri SS, Cutuli L, Amadio P, Doni A, Sironi M, Tartari S, Mantovani A, Bottazzi B, Garlanda C, Tremoli E, Catapano AL, Norata GD. Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation.
Bottazzi B, Inforzato A, Messa M, Barbagallo M, Magrini E, Garlanda C, Mantovani A. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling.
Christensen D, Mortensen R, Rosenkrands I, Dietrich J, Andersen P. Vaccine-induced TH17 cells are established as resident memory cells in the lung and promote local IgA responses.
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, Gabiria Pastore, Peter Andersen, Gianni Pozzi and Donata Medaglini Modulation of Primary immune response by Different Vaccine adjuvants
Muturi-Kioi et al. Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review
Kupz, A., U. Zedler, M. Stäber, C. Perdomo, A. Dorhoi, R. Brosch, S.H.E. Kaufmann ESAT-6-dependent cytosolic pattern recognition is essential for non-cognate, IL-18-driven, IFN-γ-mediated in vivo control of tuberculosis. J Clin Invest. 2016. doi:10.1172/JCI84978.
Legaz S, Exposito JY, Lethias C, Viginier B, Terzian C, Verrier B. Evaluation of polylactic acid nanoparticles safety using Drosophila model.
Grasse M, Meryk A, Schirmer M, Grubeck-Loebenstein B, Weinberger Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults.
Gengenbacher M1, Nieuwenhuizen N2, Vogelzang A2, Liu H2, Kaiser P2, Schuerer S, Lazar D, Wagner I, Mollenkopf HJ, Kaufmann SH. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
Huber A, Kallerup RS, Korsholm KS, Franzyk H, Lepenies B, Christensen D, Foged C, Lang R. Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo.
Jaillon S, Ponzetta A, Magrini E, Barajon I, Barbagallo M, Garlanda C, Mantovani A. Fluid phase recognition molecules in neutrophil-dependent immune responses.
Joosten SA, van Meijgaarden KE, Del Nonno F, Baiocchini A, Petrone L, Vanini V, Smits HH, Palmieri F, Goletti D, Ottenhoff TH. Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment.
John‐Paul Jukes, Uzi Gileadi, Hemza Ghadbane, Ting‐Fong Yu, Dawn Shepherd, Liam R. Cox, Gurdyal S. Besra, 2 and Vincenzo Cerundolo, Non‐glycosidic compounds can stimulate both human and mouse iNKT cells.
Kaufmann SH, Fortune S, Pepponi I, Ruhwald M, Schrager LK, Ottenhoff TH. TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines.
Andreas Kupz, Ulrike Zedler, Manuela Stäber and Stefan H. E. Kaufmann. A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation
Lambert L, Kinnear E, McDonald JU, Grodeland G, Bogen B, Stubsrud E, Lindeberg MM, Fredriksen AB, Tregoning JS.DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.
Pavot V, Climent N, Rochereau N, Garcia F, Genin C, Tiraby G, Vernejoul F, Perouzel E, Lioux T, Verrier B, Paul S. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
Proudfoot AE, Uguccioni M. Modulation of Chemokine Responses: Synergy and Cooperativity. Front Immunol. 2016 May 19;7:183.
Pinti M, Appay V, Campisi J, Frasca D, Fülöp T, Sauce D, Larbi A, Weinberger B, Cossarizza A. Aging of the immune system: Focus on inflammation and vaccination.
Platteel AC, Mishto M, Textoris-Taube K, Keller C, Liepe J, Busch DH, Kloetzel PM, Sijts AJ. CD8(+) T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products.
Platteel AC, Marit de Groot A, Keller C, Andersen P, Ovaa H, Kloetzel PM, Mishto M, Sijts AJ. Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing.
Russell RF, McDonald JU, Lambert L, Tregoning JS. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
Gutjahr A, Tiraby G, Perouzel E, Verrier B, Paul S. Triggering Intracellular Receptors for Vaccine Adjuvantation.
Wang Y, Rahman D, Mistry M, Lehner T. The Effect of Cellular Stress on T and B Cell Memory Pathways in Immunized and Unimmunized BALB/c Mice. J Biol Chem. 2016 Sep 23;291(39):20707-17.
Weinberger B. Adult vaccination against tetanus and diphtheria: the European perspective.
Woodworth JS, Cohen SB, Moguche AO, Plumlee CR, Agger EM, Urdahl KB, Andersen P. Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung.
Zimmermann N, Saiga H, Houthuys E, Moura-Alves P, Koehler A, Bandermann S, Dorhoi A, Kaufmann SH. Syndecans promote mycobacterial internalization by lung epithelial cells.
Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff TH, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SH, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups. A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Christensen D, Mortensen R, Rosenkrands I, Dietrich J, Andersen P. Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses.
Elodie Mohr, Claire-Anne Siegrist Vaccination in early life: standing up to the challenges
Rappuoli R, Bottomley MJ, D’Oro U, Finco O, De Gregorio E. Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design.
Kaufmann SH, Dorhoi A. Molecular Determinants in Phagocyte-Bacteria Interactions.
Dorhoi A, Kaufmann SH. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.
García-Sastre A. Systems vaccinology informs influenza vaccine immunogenicity.
Joshua S. Woodworth, Peter Andersen Reprogramming the T Cell Response to Tuberculosis
Dey A, Molodecky NA, Verma H, Sharma P, Yang JS, Saletti G, Ahmad M, Bahl SK, Wierzba TF, Nandy RK, Deshpande JM, Sutter RW, Czerkinsky C. Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.
Knudsen NPH, Olsen A, Buonsanti C, Follmann F, Zhang Y, Coler RN, Fox CB, Meinke A, D´Oro U, Casini D, Bonci A, Billeskov R, De Gregorio E, Rappuoli R, Harandi AM, Andersen P, AggerEA. Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T, Del Giudice G, Rappuoli R, Cerundolo V, Pollard AJ, Pulendran B, Siegrist CA. Systems biology of immunity to MF59-adjuvanted versus non-adjuvanted trivalent seasonal influenza vaccines in early childhood
